© 1993 by Oxford University Press
Journal of the National Cancer Institute, Vol. 85, No. 7, 570-574,
April 7, 1993
© 1993 Oxford University Press
Heat Shock Protein hsp70 in Patients With Axillary Lymph Node-Negative Breast Cancer: Prognostic Implications
Department of Medicine, Division of Medical Oncology, University of Texas Health Science Center at San Antonio San Antonio, Tex
Lung Biology Center, San Francisco General Hospital San Francisco, Calif
Department of Medicine, Division of Medical Oncology, University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78284-7884.
BACKGROUND:: Cell synthesis of heat shock (stress-response) proteins is increased by a variety of environmental and pathophysiological stressful conditions. The 70-kd heat shock protein (hsp70) is thought to be involved in protein-protein interactions including those of the protein products of the human c-myc on-cogene and the p53 (also known as TP53) tumor suppressor gene.
PURPOSE:: The purpose of this study was to investigate whether elevated hsp70 expression may be an indicator of biological stress experienced by a breast cancer and may, therefore, predict disease outcome.
METHODS:: Levels of hsp70 were determined by Western blot analysis in primary breast tumors from patients with negative axillary lymph nodes. We performed exploratory data analyses on a set of 162 primary breast cancers and constructed prognostic indexesof hsp70 expression levels. The optimal cutpoint for hsp70 expression was considered to be the value yielding the greatest separation for disease-free survival for the resulting two groups of patients. That cutpoint was then validated in a set of 345 tumors by univariate and multivariate analyses. Data were analyzed for overall survival, disease-free survival, tumor size, and patient age, as well as estrogen receptor and progesterone receptor status, ploidy (DNA content), and percentage of cells in S phase as determined by flow cytometry.
RESULTS:: Expression of hsp70 emerged as a useful prognostic factor, both in univariate and in multivariate analyses. Patients whose tumors had high expression of hsp70 had significantly shorter disease-free survival (P = .006). The other statistically significant factors were S-phase fraction (P = .008) and tumor size (P = .01). For patients who received adjuvant therapy, hsp70 was the only independent predictor of disease recurrence (P = .05). For those with tumors 1-3 cm in diameter, hsp70 (P = .008) and S-phase fraction (P = .02) were statistically significant predictors of recurrence.
CONCLUSIONS:: Measurement of hsp70 expression in primary tumors from patients with node-negative breast cancer may be useful in identifying patients at high risk for disease recurrence and thus may affect decisions regarding treatment after surgery.
IMPLICATIONS:: Future studies should be performed to determine if detection of hsp70 by immunohistochemistry can be used to predict clinical outcome and to betterunderstand the relationships between hsp70 and the effects of various treatment modalities.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. NAKAJIMA, H. KATO, T. MIYAZAKI, M. FUKUCHI, N. MASUDA, Y. FUKAI, M. SOHDA, F. AHMAD, and H. KUWANO Tumor Immune Systems in Esophageal Cancer with Special Reference to Heat-shock Protein 70 and Humoral Immunity Anticancer Res, May 1, 2009; 29(5): 1595 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. YOSHIDA, S. HAZAMA, K. TOKUNO, K. SAKAMOTO, M. TAKASHIMA, T. TAMESA, T. TORIGOE, N. SATO, and M. OKA Concomitant Overexpression of Heat-shock Protein 70 and HLA Class-I in Hepatitis C Virus-related Hepatocellular Carcinoma Anticancer Res, February 1, 2009; 29(2): 539 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Daugaard, T. Kirkegaard-Sorensen, M. S. Ostenfeld, M. Aaboe, M. Hoyer-Hansen, T. F. Orntoft, M. Rohde, and M. Jaattela Lens Epithelium-Derived Growth Factor Is an Hsp70-2 Regulated Guardian of Lysosomal Stability in Human Cancer Cancer Res., March 15, 2007; 67(6): 2559 - 2567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, M. A. Khaleque, M. J. Zhao, R. Zhong, M. Gaestel, and S. K. Calderwood Phosphorylation of HSF1 by MAPK-Activated Protein Kinase 2 on Serine 121, Inhibits Transcriptional Activity and Promotes HSP90 Binding J. Biol. Chem., January 13, 2006; 281(2): 782 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Clemons, K. Buzzard, R. Steel, and R. L. Anderson Hsp72 Inhibits Fas-mediated Apoptosis Upstream of the Mitochondria in Type II Cells J. Biol. Chem., March 11, 2005; 280(10): 9005 - 9012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rohde, M. Daugaard, M. H. Jensen, K. Helin, J. Nylandsted, and M. Jaattela Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms Genes & Dev., March 1, 2005; 19(5): 570 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wu, M. Osada, Z. Guo, A. Fomenkov, S. Begum, M. Zhao, S. Upadhyay, M. Xing, F. Wu, C. Moon, et al. {Delta}Np63{alpha} Up-Regulates the Hsp70 Gene in Human Cancer Cancer Res., February 1, 2005; 65(3): 758 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Fewell, C. M. Smith, M. A. Lyon, T. P. Dumitrescu, P. Wipf, B. W. Day, and J. L. Brodsky Small Molecule Modulators of Endogenous and Co-chaperone-stimulated Hsp70 ATPase Activity J. Biol. Chem., December 3, 2004; 279(49): 51131 - 51140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Harrison and K. Blackwell Hypoxia and Anemia: Factors in Decreased Sensitivity to Radiation Therapy and Chemotherapy? Oncologist, November 1, 2004; 9(suppl_5): 31 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bagatell and L. Whitesell Altered Hsp90 function in cancer: A unique therapeutic opportunity Mol. Cancer Ther., August 1, 2004; 3(8): 1021 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, J. R. Theriault, H. He, J. Gong, and S. K. Calderwood Expression of a Dominant Negative Heat Shock Factor-1 Construct Inhibits Aneuploidy in Prostate Carcinoma Cells* J. Biol. Chem., July 30, 2004; 279(31): 32651 - 32659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Hunt, D. J. Dix, G. G. Sharma, R. K. Pandita, A. Gupta, M. Funk, and T. K. Pandita Genomic Instability and Enhanced Radiosensitivity in Hsp70.1- and Hsp70.3-Deficient Mice Mol. Cell. Biol., January 15, 2004; 24(2): 899 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Norman, A. R. Localio, L. Zhou, L. Bernstein, R. J. Coates, E. W. Flagg, P. A. Marchbanks, K. E. Malone, L. K. Weiss, N. C. Lee, et al. Validation of Self-reported Screening Mammography Histories among Women with and without Breast Cancer Am. J. Epidemiol., August 1, 2003; 158(3): 264 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.B. Sugerman, N.W. Savage, L.J. Walsh, Z.Z. Zhao, X.J. Zhou, A. Khan, G.J. Seymour, and M. Bigby THE PATHOGENESIS OF ORAL LICHEN PLANUS Critical Reviews in Oral Biology & Medicine, July 1, 2002; 13(4): 350 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Cornford, A. R. Dodson, K. F. Parsons, A. D. Desmond, A. Woolfenden, M. Fordham, J. P. Neoptolemos, Y. Ke, and C. S. Foster Heat Shock Protein Expression Independently Predicts Clinical Outcome in Prostate Cancer Cancer Res., December 1, 2000; 60(24): 7099 - 7105. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Jolly and R. I. Morimoto Role of the Heat Shock Response and Molecular Chaperones in Oncogenesis and Cell Death J Natl Cancer Inst, October 4, 2000; 92(19): 1564 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bagatell, G. D. Paine-Murrieta, C. W. Taylor, E. J. Pulcini, S. Akinaga, I. J. Benjamin, and L. Whitesell Induction of a Heat Shock Factor 1-dependent Stress Response Alters the Cytotoxic Activity of Hsp90-binding Agents Clin. Cancer Res., August 1, 2000; 6(8): 3312 - 3318. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Nylandsted, M. Rohde, K. Brand, L. Bastholm, F. Elling, and M. Jaattela Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2 PNAS, July 5, 2000; 97(14): 7871 - 7876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Hoang, J. Huang, N. Rudra-Ganguly, J. Zheng, W. C. Powell, S. K. Rabindran, C. Wu, and P. Roy-Burman A Novel Association between the Human Heat Shock Transcription Factor 1 (HSF1) and Prostate Adenocarcinoma Am. J. Pathol., March 1, 2000; 156(3): 857 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Smith, L. Whitesell, and E. Katsanis Molecular Chaperones: Biology and Prospects for Pharmacological Intervention Pharmacol. Rev., December 1, 1998; 50(4): 493 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Buzzard, A. J. Giaccia, M. Killender, and R. L. Anderson Heat Shock Protein 72 Modulates Pathways of Stress-induced Apoptosis J. Biol. Chem., July 3, 1998; 273(27): 17147 - 17153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. McMillan, X. Xiao, L. Shao, K. Graves, and I. J. Benjamin Targeted Disruption of Heat Shock Transcription Factor 1 Abolishes Thermotolerance and Protection against Heat-inducible Apoptosis J. Biol. Chem., March 27, 1998; 273(13): 7523 - 7528. [Abstract] [Full Text] [PDF]
|
|